OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AMAL57

Amal Ltd

Commodity ChemicalsVerified

Amal Limited maintains a strong liquidity position, with a current ratio of 2.48, indicating that the company has more than double the current assets to cover its current liabilities. The company's cash and equivalents amount to INR 21.14 million, and it generates positive free cash flow of INR 23.62 million, supporting its operational flexibility. The debt-to-equity ratio is 0.0, suggesting that the company is not leveraged and relies primarily on equity financing. In terms of profitability, Amal Limited reports a return on equity (ROE) of 18.6% and a return on assets (ROA) of 14.52%, both of which are strong indicators of efficient capital utilization and profitability. These metrics are well above the typical thresholds for the Commodity Chemicals industry, where ROE and ROA are often lower due to the capital-intensive nature of the sector. The company's revenue is concentrated in a single business segment, as it operates primarily in the production of bulk and downstream chemicals. Geographically, the company is entirely focused on the Indian market, with its manufacturing plant located in Ankleshwar, Gujarat. This concentration may expose the company to regional economic and regulatory risks, but it also allows for tight control over operations and supply chain logistics. Amal Limited's growth trajectory is supported by its strong operating cash flow of INR 216.96 million and a net income of INR 223.84 million. While the company has not disclosed specific growth targets, its current financial performance suggests a stable and potentially growing business. The company's capital expenditure of INR -68.33 million indicates a reduction in capital spending, which may be a strategic move to preserve cash or optimize existing assets. The risk assessment for Amal Limited indicates low liquidity and dilution risks. The company has no immediate filing-based liquidity or dilution flags, and its capital structure is not burdened by debt. The absence of dilution risk is further supported by the fact that the number of shares outstanding remains unchanged between basic and diluted shares. Recent events and filings do not indicate any material changes in the company's operations or financial position. The company's latest financial snapshot, as of the HA-latest data, shows consistent performance without any significant deviations or red flags. The company's focus on maintaining a strong liquidity position and efficient capital utilization supports its current stability.

30-day price · AMAL+125.45 (+27.3%)
Low$408.20High$715.00Close$584.95As of11 May, 00:00 UTC
Profile
CompanyAmal Ltd
TickerAMAL.BO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Amal Limited is an India-based chemical company engaged in the manufacturing and marketing of bulk chemicals such as sulfuric acid and oleum, along with downstream products like sulfur dioxide and sulfur trioxide, which are used in industries including dyestuff, fertilizer, personal care, petrochemical, pharmaceutical, and textile.

Classification. Amal Limited is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

Amal Limited maintains a strong liquidity position, with a current ratio of 2.48, indicating that the company has more than double the current assets to cover its current liabilities. The company's cash and equivalents amount to INR 21.14 million, and it generates positive free cash flow of INR 23.62 million, supporting its operational flexibility. The debt-to-equity ratio is 0.0, suggesting that the company is not leveraged and relies primarily on equity financing. In terms of profitability, Amal Limited reports a return on equity (ROE) of 18.6% and a return on assets (ROA) of 14.52%, both of which are strong indicators of efficient capital utilization and profitability. These metrics are well above the typical thresholds for the Commodity Chemicals industry, where ROE and ROA are often lower due to the capital-intensive nature of the sector. The company's revenue is concentrated in a single business segment, as it operates primarily in the production of bulk and downstream chemicals. Geographically, the company is entirely focused on the Indian market, with its manufacturing plant located in Ankleshwar, Gujarat. This concentration may expose the company to regional economic and regulatory risks, but it also allows for tight control over operations and supply chain logistics. Amal Limited's growth trajectory is supported by its strong operating cash flow of INR 216.96 million and a net income of INR 223.84 million. While the company has not disclosed specific growth targets, its current financial performance suggests a stable and potentially growing business. The company's capital expenditure of INR -68.33 million indicates a reduction in capital spending, which may be a strategic move to preserve cash or optimize existing assets. The risk assessment for Amal Limited indicates low liquidity and dilution risks. The company has no immediate filing-based liquidity or dilution flags, and its capital structure is not burdened by debt. The absence of dilution risk is further supported by the fact that the number of shares outstanding remains unchanged between basic and diluted shares. Recent events and filings do not indicate any material changes in the company's operations or financial position. The company's latest financial snapshot, as of the HA-latest data, shows consistent performance without any significant deviations or red flags. The company's focus on maintaining a strong liquidity position and efficient capital utilization supports its current stability.
Key takeaways
  • Amal Limited maintains a strong liquidity position with a current ratio of 2.48 and no debt, indicating a solid financial foundation.
  • The company's profitability is robust, with a return on equity of 18.6% and a return on assets of 14.52%, outperforming typical industry benchmarks.
  • The company's operations are concentrated in a single business segment and geographic region, which may limit diversification but allows for operational control.
  • Amal Limited's capital expenditure has decreased, suggesting a strategic focus on preserving cash and optimizing existing assets.
  • The company faces low liquidity and dilution risks, with no immediate flags or concerns identified in the latest filings.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$2.40B
Gross profit$514.7M
Operating income$263.6M
Net income$223.8M
R&D
SG&A
D&A
SBC
Operating cash flow$217.0M
CapEx-$68.3M
Free cash flow$236.2M
Total assets$1.54B
Total liabilities$338.0M
Total equity$1.20B
Cash & equivalents$21.1M
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.20B
Net cash$21.1M
Current ratio2.5
Debt/Equity0.0
ROA14.5%
ROE18.6%
Cash conversion97.0%
CapEx/Revenue-2.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricAMALActivity
Op margin11.0%0.4% medp25 -8.0% · p75 16.0%above median
Net margin9.3%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin21.5%20.8% medp25 14.9% · p75 24.0%above median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-2.9%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity0.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 09:05 UTC#c8126bc4
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 09:08 UTCJob: 92ca06cd